Navdip Ghai Merck Sharpe & Dohme

Navdip Ghai is a Regulatory CMC professional at Merck Sharp & Dohme based in the USA and leads a team supporting HPV (Human Papillomavirus) vaccines in global markets. His career spans over 23 years in Bio-pharmaceutical industry with various roles in technical operations, validation, regulatory affairs, and CMC. He has deep exposure to China regulatory environment having led initial approval and renewals of 2 HPV vaccines in China.